Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. [electronic resource]
Producer: 20121024Description: 303-9 p. digitalISSN:- 1878-4119
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Bicuspid
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- diagnosis
- Bone Density Conservation Agents -- administration & dosage
- Breast Neoplasms -- drug therapy
- Dental Arch -- drug effects
- Diphosphonates -- administration & dosage
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Injections, Intravenous
- Male
- Mandibular Diseases -- chemically induced
- Middle Aged
- Molar
- Multiple Myeloma -- drug therapy
- Neoplasms -- drug therapy
- Osteoporosis -- drug therapy
- Prostatic Neoplasms -- drug therapy
- Retrospective Studies
- Risk Factors
- Thalidomide -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.